Position in MRK
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$300,818
+$6,108 QoQ
Shares Held
2,341
-4.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#3,166
of 3,769 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026REAP Financial Group, LLC holds $2,655,040 across 8 Drug Manufacturers - General names. MRK ranks #4 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
3,097 | $786,545 | |
| 2 | LLY |
ELI LILLY & Co
|
502 | $602,113 | |
| 3 | ABBV |
AbbVie Inc.
|
2,018 | $507,809 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
2,341 | $300,818 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,239 | $156,535 | |
| 6 | PFE |
Pfizer Inc
|
6,242 | $150,307 | |
| 7 | AMGN |
Amgen Inc
|
271 | $98,134 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
916 | $52,779 |
All Filings in MRK
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $300,818 | 2,341 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $294,710 | 2,450 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $205,257 | 1,950 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $148,052 | 1,764 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $114,386 | 1,445 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $76,655 | 854 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $43,970 | 442 | Shares | Sole | 2025-02-27 | |
| 2024-09-30 | $53,486 | 471 | Shares | Sole | 2025-02-27 | |
| 2024-06-30 | $40,730 | 329 | Shares | Sole | 2025-02-27 | |
| 2024-03-31 | $35,098 | 266 | Shares | Sole | 2025-02-27 | |
| 2023-12-31 | $187,950 | 1,724 | Shares | Sole | 2025-02-27 | |
| No filing history on record for this holder in this stock. | ||||||